<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="163008">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01756196</url>
  </required_header>
  <id_info>
    <org_study_id>B-1008/016-004</org_study_id>
    <nct_id>NCT01756196</nct_id>
  </id_info>
  <brief_title>Incidence of Various Types of Systemic Reactions Related to Spinal Steroid Injection: A Prospective Study</brief_title>
  <official_title>Prospective Observational Study of Evaluate the Incidence and Types of Systemic Reactions After Spinal Steroid Injections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many systemic reactions occur commonly after spinal steroid injections, especially in
      patients, and may be associated with underlying disease, such as hypertension and diabetes
      mellitus, as well as steroid dose and repetition of spinal steroid injection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluate the incidence and types of systemic reactions after spinal steroid injections and
      to investigate the association of spinal steroid injection with patient demographics,
      history of previous injections, type and dose of steroid, and method and site of previous
      and current injections.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>2 Weeks</target_duration>
  <primary_outcome>
    <measure>episodes of systemic reactions after spinal steroid injection</measure>
    <time_frame>2 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation of episodes of systemic reactions after spinal steroid injection</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">997</enrollment>
  <condition>Incidence and Types of Systemic Reactions Occurring After Spinal Steroid Injection in a Large Population</condition>
  <arm_group>
    <arm_group_label>Steroid Injection</arm_group_label>
    <description>Reactions associated with spinal steroid injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Spinal Steroid Injection</intervention_name>
    <description>Steroid Injection</description>
    <arm_group_label>Steroid Injection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients receiving the injection were informed of the aim and protocol of this study
        and the possible local and systemic reactions associated with spinal steroid injection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indicaion of steroid injction.

        Exclusion Criteria:

          -  Contraindiation of steroid injction.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>94 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seoung Nam</city>
        <state>Bundang</state>
        <zip>463-802</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Goldstein G, Schlesinger DH. Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin. Lancet. 1975 Aug 9;2(7928):256-9.</citation>
    <PMID>49801</PMID>
  </results_reference>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 19, 2012</lastchanged_date>
  <firstreceived_date>December 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Guen Young Lee</investigator_full_name>
    <investigator_title>Associate Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Spinal injection; Steroid; Systemic reaction; Complication; Side effect; Diabetes mellitus; Hypertension; Risk factor</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
